Guanhao Biotech released its performance for the first three quarters, with a net profit attributable to the parent company of 26.7185 million yuan, a decrease of 4.02%Zhitong·Oct 28, 2025 at 04:54 AM300238+3.14%
Guanhao Biotech: Net profit of 20.4041 million yuan in the first half of 2025, a year-on-year increase of 1.27%Zhitong·Aug 27, 2025 at 05:56 AM300238+3.14%
Biological vaccine stocks strengthened, among which, Shen Lian Biomedical rose over 10%, Global Printing 10CM hit the daily limit, Guanhao Biotech and Sinovac Biotech rose over 7%, Saili Medical rose over 5%, Kanglao Weishi, Jinhe Biotechnology, and Vland Biotech rose over 4%, Yongshun Biotech, Dezhan Health, Junzheng Group, and Kanghua Biotech rose over 3%Zhitong·Jul 31, 2025 at 08:50 PM300238+3.14%603739+1.26%
The concept of innovative drugs remains active, with Xintian Pharma and others hitting the daily limitZhitong·Jul 31, 2025 at 08:42 PM002287+0.38%600513+3.34%
The medical device sector saw a short-term surge, with JG Development hitting the daily limitZhitong·Jul 6, 2025 at 08:40 PM300238+3.14%688236+1.21%
Guanhao Biotech terminates the issuance of stocks to specific objects and withdraws the application documentsZhitong·Jun 23, 2025 at 06:23 AM300238+3.14%
The three major A-share indices opened mixed, with energy stocks declining36Kr·Jun 16, 2025 at 08:32 PM688658+2.16%300238+3.14%
The three major A-share indices closed higher collectively36Kr·Jun 3, 2025 at 02:03 AM002946+2.47%002230+5.89%
Brain-computer interface concept stocks collectively strengthened, among which, Guanhao Biotech rose over 17%, HAINAN HAIYAO hit the 10% daily limit, Beilu Pharma rose over 8%, Xiangyu Medical rose over 7%, and SINOMED and Innovative Medical rose over 5%Zhitong·Jun 3, 2025 at 12:27 AM300016+2.63%688626+5.52%
The concept of brain-computer interfaces experiences a surge, Innovative Medical hits the daily limit upZhitong·May 29, 2025 at 08:55 PM688626+5.52%300753+2.96%
Guanhao Biotech released its Q1 2025 performance, with a net profit attributable to the parent company of 14.8661 million yuan, a year-on-year increase of 3.3%Zhitong·Apr 22, 2025 at 11:01 AM300238+3.14%
Guanhao Biotech released its 2024 annual performance, with a net profit attributable to the parent company of 27.4169 million yuan, a year-on-year decrease of 11.57%Zhitong·Apr 22, 2025 at 10:59 AM300238+3.14%
Guanhao Biotech and others invest to establish a new biotechnology companyZhitong·Mar 20, 2025 at 08:49 PM300238+3.14%
China's first stem cell therapy drug is on the market! Multiple listed companies respondUSHK News·Jan 2, 2025 at 09:37 PM000504+2.44%300238+3.14%
